questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Fibrose
Fibrose : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Fibrose pulmonaire
Biopsie
Imagerie médicale
Tests sanguins
Inflammation
Fonction hépatique
Échographie
Fibrose hépatique
Imagerie
Radiologie
Fibrose
Opacités
Pneumonie
Cirrhose
Diagnostic différentiel
Symptômes
5
Fibrose pulmonaire
Toux
Essoufflement
Fibrose hépatique
Douleur abdominale
Symptômes
Fibrose cardiaque
Palpitations
Œdèmes
Perte de poids
Fibrose
Malabsorption
Fibrose systémique
Douleurs articulaires
Raideur cutanée
Prévention
5
Prévention
Tabagisme
Polluants
Fibrose hépatique
Mode de vie sain
Vaccination
Examens réguliers
Détection précoce
Fibrose
Alimentation
Antioxydants
Prévention
Maladies chroniques
Diabète
Hypertension
Traitements
5
Fibrose pulmonaire
Antifibrotiques
Réhabilitation pulmonaire
Transplantation
Chirurgie
Fibrose
Fibrose hépatique
Antiviraux
Médicaments
Physiothérapie
Fibrose
Qualité de vie
Traitements naturels
Antioxydants
Consultation médicale
Complications
5
Complications
Insuffisance respiratoire
Infections pulmonaires
Cirrhose
Fibrose hépatique
Complications
Fibrose cardiaque
Insuffisance cardiaque
Accidents vasculaires cérébraux
Qualité de vie
Fibrose
Limitations
Complications psychologiques
Anxiété
Dépression
Facteurs de risque
5
Facteurs de risque
Tabagisme
Infections
Âge
Fibrose
Facteurs de risque
Maladies auto-immunes
Sclérodermie
Fibrose
Diabète
Fibrose hépatique
Stéatose
Exposition professionnelle
Fibrose
Produits chimiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fibrose : Questions médicales les plus fréquentes",
"headline": "Fibrose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fibrose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-06",
"dateModified": "2025-04-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fibrose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Processus pathologiques",
"url": "https://questionsmedicales.fr/mesh/D010335",
"about": {
"@type": "MedicalCondition",
"name": "Processus pathologiques",
"code": {
"@type": "MedicalCode",
"code": "D010335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cicatrice hypertrophique",
"alternateName": "Cicatrix, Hypertrophic",
"url": "https://questionsmedicales.fr/mesh/D017439",
"about": {
"@type": "MedicalCondition",
"name": "Cicatrice hypertrophique",
"code": {
"@type": "MedicalCode",
"code": "D017439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.274.505"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chéloïde",
"alternateName": "Keloid",
"url": "https://questionsmedicales.fr/mesh/D007627",
"about": {
"@type": "MedicalCondition",
"name": "Chéloïde",
"code": {
"@type": "MedicalCode",
"code": "D007627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.274.510"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adhérences tissulaires",
"alternateName": "Tissue Adhesions",
"url": "https://questionsmedicales.fr/mesh/D000267",
"about": {
"@type": "MedicalCondition",
"name": "Adhérences tissulaires",
"code": {
"@type": "MedicalCode",
"code": "D000267",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.274.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cirrhose du foie",
"alternateName": "Liver Cirrhosis",
"url": "https://questionsmedicales.fr/mesh/D008103",
"about": {
"@type": "MedicalCondition",
"name": "Cirrhose du foie",
"code": {
"@type": "MedicalCode",
"code": "D008103",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.412"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cirrhose biliaire",
"alternateName": "Liver Cirrhosis, Biliary",
"url": "https://questionsmedicales.fr/mesh/D008105",
"about": {
"@type": "MedicalCondition",
"name": "Cirrhose biliaire",
"code": {
"@type": "MedicalCode",
"code": "D008105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.412.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Fibrose systémique néphrogénique",
"alternateName": "Nephrogenic Fibrosing Dermopathy",
"url": "https://questionsmedicales.fr/mesh/D054989",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose systémique néphrogénique",
"code": {
"@type": "MedicalCode",
"code": "D054989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibrose péritonéale",
"alternateName": "Peritoneal Fibrosis",
"url": "https://questionsmedicales.fr/mesh/D056627",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose péritonéale",
"code": {
"@type": "MedicalCode",
"code": "D056627",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibrose pulmonaire",
"alternateName": "Pulmonary Fibrosis",
"url": "https://questionsmedicales.fr/mesh/D011658",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D011658",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.644"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibrose rétropéritonéale",
"alternateName": "Retroperitoneal Fibrosis",
"url": "https://questionsmedicales.fr/mesh/D012185",
"about": {
"@type": "MedicalCondition",
"name": "Fibrose rétropéritonéale",
"code": {
"@type": "MedicalCode",
"code": "D012185",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.355.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Fibrose",
"alternateName": "Fibrosis",
"code": {
"@type": "MedicalCode",
"code": "D005355",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nikolaos G Frangogiannis",
"url": "https://questionsmedicales.fr/author/Nikolaos%20G%20Frangogiannis",
"affiliation": {
"@type": "Organization",
"name": "The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: nikolaos.frangogiannis@einsteinmed.org."
}
},
{
"@type": "Person",
"name": "Pierre-Régis Burgel",
"url": "https://questionsmedicales.fr/author/Pierre-R%C3%A9gis%20Burgel",
"affiliation": {
"@type": "Organization",
"name": "Université Paris Cité and Institut Cochin, Inserm U1016, Paris, France."
}
},
{
"@type": "Person",
"name": "Jane C Davies",
"url": "https://questionsmedicales.fr/author/Jane%20C%20Davies",
"affiliation": {
"@type": "Organization",
"name": "National Heart & Lung Institute, Imperial College London, London, UK."
}
},
{
"@type": "Person",
"name": "Na Liu",
"url": "https://questionsmedicales.fr/author/Na%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Nanjing, Jiangsu, China."
}
},
{
"@type": "Person",
"name": "Ruoshui Li",
"url": "https://questionsmedicales.fr/author/Ruoshui%20Li",
"affiliation": {
"@type": "Organization",
"name": "The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan.",
"datePublished": "2024-07-01",
"url": "https://questionsmedicales.fr/article/39023895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.19873"
}
},
{
"@type": "ScholarlyArticle",
"name": "The utility of liver function tests and abdominal ultrasound in infectious mononucleosis-A systematic review.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35834363",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/coa.13965"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Value of Non-invasive Liver Function Tests in Liver Fibrosis and Changes in These Parameters Post-metabolic Surgery.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36538211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11695-022-06416-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Abnormal liver function tests and improved survival in a child with splice mutation TARP syndrome.",
"datePublished": "2023-03-21",
"url": "https://questionsmedicales.fr/article/36944446",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2022-253035"
}
},
{
"@type": "ScholarlyArticle",
"name": "A literature review of liver function test elevations in rifampin drug-drug interaction studies.",
"datePublished": "2022-05-09",
"url": "https://questionsmedicales.fr/article/35470578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cts.13281"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Fibrose",
"item": "https://questionsmedicales.fr/mesh/D005355"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fibrose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fibrose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fibrose",
"description": "Comment diagnostique-t-on la fibrose pulmonaire ?\nQuels tests sanguins sont utiles pour la fibrose ?\nLa fibrose peut-elle être détectée par échographie ?\nQuels sont les signes radiologiques de la fibrose ?\nLa fibrose peut-elle être confondue avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fibrose",
"description": "Quels sont les symptômes de la fibrose pulmonaire ?\nLa fibrose hépatique provoque-t-elle des douleurs ?\nQuels signes indiquent une fibrose cardiaque ?\nLa fibrose peut-elle entraîner une perte de poids ?\nQuels symptômes sont associés à la fibrose systémique ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fibrose",
"description": "Comment prévenir la fibrose pulmonaire ?\nPeut-on prévenir la fibrose hépatique ?\nLes examens réguliers aident-ils à prévenir la fibrose ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe contrôle des maladies chroniques aide-t-il ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fibrose",
"description": "Quels traitements existent pour la fibrose pulmonaire ?\nLa chirurgie est-elle une option pour la fibrose ?\nQuels médicaments sont utilisés pour la fibrose hépatique ?\nLa physiothérapie aide-t-elle en cas de fibrose ?\nY a-t-il des traitements naturels pour la fibrose ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fibrose",
"description": "Quelles sont les complications de la fibrose pulmonaire ?\nLa fibrose hépatique peut-elle entraîner une cirrhose ?\nQuels risques sont associés à la fibrose cardiaque ?\nLa fibrose peut-elle affecter la qualité de vie ?\nY a-t-il des complications psychologiques liées à la fibrose ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fibrose",
"description": "Quels sont les facteurs de risque de la fibrose pulmonaire ?\nL'âge est-il un facteur de risque pour la fibrose ?\nLes maladies auto-immunes augmentent-elles le risque de fibrose ?\nLe diabète est-il un facteur de risque pour la fibrose hépatique ?\nL'exposition professionnelle influence-t-elle le risque de fibrose ?",
"url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Liver+Function+Tests#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la fibrose pulmonaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens d'imagerie, des tests fonctionnels pulmonaires et parfois une biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles pour la fibrose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests pour évaluer les marqueurs inflammatoires et la fonction hépatique peuvent être effectués."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle être détectée par échographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie peut aider à visualiser la fibrose dans certains organes comme le foie."
}
},
{
"@type": "Question",
"name": "Quels sont les signes radiologiques de la fibrose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des opacités, des réticulations et des anomalies de la structure tissulaire."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle être confondue avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec des maladies comme la pneumonie ou la cirrhose."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la fibrose pulmonaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une toux persistante, un essoufflement et une fatigue chronique."
}
},
{
"@type": "Question",
"name": "La fibrose hépatique provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des douleurs abdominales et une sensation de lourdeur dans l'abdomen."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une fibrose cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des palpitations, un essoufflement à l'effort et des œdèmes."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle entraîner une perte de poids ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fibrose peut causer une perte de poids due à une mauvaise absorption des nutriments."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la fibrose systémique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs articulaires, une raideur cutanée et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir la fibrose pulmonaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, réduire l'exposition à des polluants et traiter les infections respiratoires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la fibrose hépatique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en adoptant un mode de vie sain, en évitant l'alcool et en se vaccinant contre l'hépatite."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à prévenir la fibrose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent détecter précocement des maladies pouvant mener à la fibrose."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée riche en antioxydants peut aider à prévenir la fibrose."
}
},
{
"@type": "Question",
"name": "Le contrôle des maladies chroniques aide-t-il ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien gérer des maladies comme le diabète ou l'hypertension peut réduire le risque de fibrose."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la fibrose pulmonaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments antifibrotiques, la réhabilitation pulmonaire et l'oxygénothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour la fibrose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certains cas avancés, une transplantation d'organe peut être envisagée."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour la fibrose hépatique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments pour traiter la cause sous-jacente, comme les antiviraux pour l'hépatite, sont utilisés."
}
},
{
"@type": "Question",
"name": "La physiothérapie aide-t-elle en cas de fibrose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut améliorer la fonction pulmonaire et la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour la fibrose ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines approches comme les antioxydants peuvent aider, mais il faut consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la fibrose pulmonaire ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire, les infections pulmonaires et les embolies."
}
},
{
"@type": "Question",
"name": "La fibrose hépatique peut-elle entraîner une cirrhose ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fibrose hépatique peut évoluer vers une cirrhose, entraînant des complications graves."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à la fibrose cardiaque ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent l'insuffisance cardiaque, les arythmies et les accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "La fibrose peut-elle affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut réduire la qualité de vie en limitant les activités quotidiennes et en causant de la douleur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications psychologiques liées à la fibrose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent éprouver de l'anxiété et de la dépression en raison de leur état de santé."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la fibrose pulmonaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des substances toxiques et des infections antérieures."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour la fibrose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de fibrose augmente avec l'âge, surtout après 50 ans."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque de fibrose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérodermie peuvent prédisposer à la fibrose dans divers organes."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour la fibrose hépatique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le risque de fibrose hépatique en raison de la stéatose."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle influence-t-elle le risque de fibrose ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des professions exposant à des poussières ou des produits chimiques peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: nikolaos.frangogiannis@einsteinmed.org.
Publications dans "Fibrose" :
2 publications dans cette catégorie
Affiliations :
Université Paris Cité and Institut Cochin, Inserm U1016, Paris, France.
Department of Respiratory Medicine and National Reference Center for Cystic Fibrosis, Cochin Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France.
Publications dans "Fibrose" :
2 publications dans cette catégorie
Affiliations :
National Heart & Lung Institute, Imperial College London, London, UK.
St Thomas' NHS Trust, London, UK.
Royal Brompton Hospital, Part of Guy's & St Thomas' Trust, London, UK.
Publications dans "Fibrose" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Nanjing, Jiangsu, China.
Publications dans "Fibrose" :
2 publications dans cette catégorie
Affiliations :
The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, United States of America.
Publications dans "Fibrose" :
2 publications dans cette catégorie
Affiliations :
1Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Adult Cystic Fibrosis Centre, Royal Brompton Hospital and Imperial College, London SW3 6NP, United Kingdom. Electronic address: n.simmonds@imperial.ac.uk.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, USA. rgzhao@buffalo.edu.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Section of Pulmonary and Critical Care, Department at University of Chicago, 5841 South Maryland Avenue, MC 6076, Chicago, IL 60637, USA.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Interstitial Lung Disease Program, Section of Pulmonary/Critical Care, University of Chicago, Chicago, IL, USA. Electronic address: deji@uchicago.edu.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padova, Padua, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Medical and Surgical Sciences, University Hospital of Modena, Respiratory Diseases Unit and Centre for Rare Lung Diseases, University of Modena Reggio Emilia, Modena, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, Modena, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Medical and Surgical Sciences, University Hospital of Modena, Internal Medicine Unit, University of Modena Reggio Emilia, Modena, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Medical and Surgical Sciences, University Hospital of Modena, Respiratory Diseases Unit and Centre for Rare Lung Diseases, University of Modena Reggio Emilia, Modena, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Medical and Surgical Sciences, University Hospital of Modena, Respiratory Diseases Unit and Centre for Rare Lung Diseases, University of Modena Reggio Emilia, Modena, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena Reggio Emilia, Modena, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Surgical, Oncological and Gastroenterological Sciences, Unit of Gastroenterology, University of Padova, Padua, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Surgical, Oncological and Gastroenterological Sciences, Unit of Gastroenterology, University of Padova, Padua, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Medical and Surgical Sciences, University Hospital of Modena, Internal Medicine Unit, University of Modena Reggio Emilia, Modena, Italy.
Publications dans "Fibrose" :
1 publication dans cette catégorie
Affiliations :
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padova, Padua, Italy.
Publications dans "Fibrose" :
Endothelin receptor antagonists are first-line therapy for pulmonary arterial hypertension (PAH). The first 2 agents approved in the class, bosentan and ambrisentan, initially carried boxed warnings f...
To analyze changes in the use of and LFT monitoring for ambrisentan and bosentan after changes to the ambrisentan labeling and REMS....
This serial cross-sectional study used data from 3 longitudinal health care insurance claims databases-Medicaid, Optum's deidentified Clinformatics Data Mart, and Merative Marketscan-to perform an int...
Removal of the boxed warning for hepatotoxicity and the REMS LFT monitoring requirements on ambrisentan in March 2011....
The primary outcomes were use of ambrisentan (ie, individuals with at least 1 dispensing per 1 000 000 individuals enrolled in the 3 datasets) vs bosentan and LFT monitoring (ie, proportion of initiat...
A total of 10 261 patients received a prescription for ambrisentan during the study period (7442 women [72.5%]; mean [SD] age, 52.6 [17.6] years), and 11 159 patients received a prescription for bosen...
In this serial cross-sectional study of ambrisentan, labeling changes and removal of the REMS-related LFT requirement were associated with shifts in prescribing and testing behavior for ambrisentan bu...
A large proportion of patients with infectious mononucleosis (IM) have abnormal liver function tests (LFT) at presentation. There is no guideline regarding the management and follow-up of these patien...
A systematic search of PubMed, EMBASE and the Cochrane library was done. Two authors independently screened records for eligibility using pre-defined criteria. We included both adult and paediatric po...
A total of 3924 patients were included from 32 studies, of which LFT values were reported on 2779 patients. A combination of typical clinical features, heterophile antibodies and Epstein-Barr virus-sp...
Current evidence questions the need for routine assessment of LFT in immunocompetent patients presenting with IM; serial LFT assessments following initial abnormalities are not required in immunocompe...
This study aimed to ascertain the diagnostic accuracy of non-invasive liver function tests in liver fibrosis and assess their changes after metabolic surgery....
1005 individuals with severe obesity who were referred for metabolic surgery were analysed. All participants had blood samples taken for liver enzymes and lipid profile. In addition, hepatic indexes, ...
AST/ALT (AAR) was the most sensitive (79%) pre-operative non-invasive serological marker for detecting liver fibrosis, whereas NAFLD Fibrosis Score (NFS) was the most specific (84%). AST/upper limit o...
AAR has a high sensitivity, whereas NFS exhibits a high specificity in diagnosing liver fibrosis. The authors recommend using both investigations in conjunction with 2D-SWE to increase the likelihood ...
TARP (talipes equinovarus, atrial septal defect (ASD), Robin sequence, persistent left superior vena cava) syndrome is a rare X-linked disorder affecting the...
Although rifampin drug-drug interaction (DDI) studies are routinely conducted, there have been instances of liver function test (LFT) elevations, warranting further evaluation. A literature review was...
To compare the dynamic changes in future liver remnant (FLR) function and volume after hepatectomy and to evaluate the associations between three modalities in assessment of liver function....
Liver function and volume were quantified pre-operatively, at post-operative day (POD) 7 and POD 28 in 10 patients with colorectal liver metastases undergoing hemihepatectomy using the indocyanine gre...
Increase in liver function ranged from 13 to 152% (median 92%) and in volume from 37 to 134% (median 79%). There was no significant discrepancy in increase between FLR function and volume during the f...
The observed growth in FLR volume is closely related to the functional increase within 1 month after hepatectomy. Gadoxetic acid-enhanced MRI might substitute HBS for regional liver function assessmen...
Liver function growth was parallel with liver volume increase during the perioperative period. Liver function assessment with gadoxetic acid-enhanced MRI was comparable with that of HBS indicating tha...
Post-stroke depression (PSD) was one of the most prevalent and serious neuropsychiatric effects after stroke. Nevertheless, the association between liver function test indices and PSD remains elusive,...
All patients were selected from seven medical institutions of Chongqing Medical University from 2015 to 2021. Variables including demographic characteristics and liver function test indices were colle...
A total of 464 PSD and 1621 stroke patients met the inclusion criteria. Six liver function test items, namely AST, ALT, TBA, TBil, TP, ALB/GLB, were closely associated with PSD, and included for the c...
The prediction model constructed using these six predictors with GBDT algorithm displayed a promising prediction ability, which could be used for the participating hospital units or individuals by mob...
Liver function tests are frequently used to screen liver function, monitor therapy, and determine the severity of liver problems. The present study aimed to assess the consistency of the results of th...
Since the advent of direct-acting antiviral therapy, the elimination of hepatitis c virus (HCV) as a public health concern is now possible. However, identification of those who remain undiagnosed, and...
The liver is a critical organ at risk during right breast radiotherapy (RT). Liver function tests (LFTs) such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl tr...
Between January 2019 and November 2022, data from 100 patients who underwent adjuvant right breast RT across three centers were retrospectively assessed. Target volumes and normal structures were cont...
The median age among the 100 patients was 56 (range: 29-79). Breast-conserving surgery was performed on 75% of the patients. The most common T and N stages were T1 (53%) and N0 (53%), respectively. No...
Due to factors such as anatomical positioning, planning technique, and breast posture, the liver can receive varying doses during right breast irradiation. Protecting patients from liver toxicity seco...